Top

Journal of Cancer Research and Clinical Oncology

Published in:

13-04-2023 | Lung Cancer | Review

Shedding light on macrophage immunotherapy in lung cancer

Authors: Huiyun Ma, Zhouwei Zhang, Qin Hu, Hongyu Chen, Gujie Wu, Youlang Zhou, Qun Xue

Published in: Journal of Cancer Research and Clinical Oncology | Issue 10/2023

Abstract

The search for therapeutic options for lung cancer continues to advance, with rapid advances in the search for therapies to improve patient prognosis. At present, systemic chemotherapy, immune checkpoint inhibitor therapy, antiangiogenic therapy, and targeted therapy for driver gene positivity are available in the clinic. Common clinical treatments fail to achieve desired outcomes due to immunosuppression of the tumor microenvironment (TME). Tumor immune evasion is mediated by cytokines, chemokines, immune cells, and other cells such as vascular endothelial cells within the tumor immune microenvironment. Tumor-associated macrophages (TAMs) are important immune cells in the TME, inducing tumor angiogenesis, encouraging tumor cell proliferation and migration, and suppressing antitumor immune responses. Thus, TAM targeting becomes the key to lung cancer immunotherapy. This review focuses on macrophage phenotype, polarization mechanism, role in lung cancer, and advances in macrophage centric immunotherapies.

Available only for authorised users

Anfray C, Ummarino A, Andon FT, Allavena P (2019) Current strategies to target tumor-associated-macrophages to improve anti-tumor immune responses. Cells 9(1):46PubMedPubMedCentral

Baghdadi M, Wada H, Nakanishi S, Abe H, Han N, Putra WE et al (2016) Chemotherapy-induced IL34 enhances immunosuppression by tumor-associated macrophages and mediates survival of chemoresistant lung cancer cells. Cancer Res 76(20):6030–6042PubMed

Barclay AN, Van den Berg TK (2014) The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target. Annu Rev Immunol 32:25–50PubMed

Bonde AK, Tischler V, Kumar S, Soltermann A, Schwendener RA (2012) Intratumoral macrophages contribute to epithelial–mesenchymal transition in solid tumors. BMC Cancer 12:35PubMedPubMedCentral

Bremnes RM, Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Sirera R et al (2011) The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol 6(1):209–217PubMed

Cai H, Zhang Y, Wang J, Gu J (2021) Defects in macrophage reprogramming in cancer therapy: the negative impact of PD-L1/PD-1. Front Immunol 12:690869PubMedPubMedCentral

Chen J, Zhang K, Zhi Y, Wu Y, Chen B, Bai J et al (2021) Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway. Clin Transl Med 11(9):e478PubMedPubMedCentral

Cheng C, Hu Z, Cao L, Peng C, He Y (2019) The scavenger receptor SCARA1 (CD204) recognizes dead cells through spectrin. J Biol Chem 294(49):18881–18897PubMedPubMedCentral

Cotechini T, Atallah A, Grossman A (2021) Tissue-resident and recruited macrophages in primary tumor and metastatic microenvironments: potential targets in cancer therapy. Cells 10(4):960PubMedPubMedCentral

Cruz-Bermudez A, Laza-Briviesca R, Vicente-Blanco RJ, Garcia-Grande A, Coronado MJ, Laine-Menendez S et al (2019) Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-beta signaling. Free Radic Biol Med 130:163–173PubMed

Dai X, Lu L, Deng S, Meng J, Wan C, Huang J et al (2020) USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer. Theranostics 10(20):9332–9347PubMedPubMedCentral

da Silva MC, Breckwoldt MO, Vinchi F, Correia MP, Stojanovic A, Thielmann CM et al (2017) Iron induces anti-tumor activity in tumor-associated macrophages. Front Immunol 8:1479

DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19(6):369–382PubMedPubMedCentral

Deng P, Zhou R, Zhang J, Cao L (2021) Increased expression of KNSTRN in lung adenocarcinoma predicts poor prognosis: a bioinformatics analysis based on TCGA data. J Cancer 12(11):3239–3248PubMedPubMedCentral

Deng L, Jian Z, Xu T, Li F, Deng H, Zhou Y et al (2023) Macrophage polarization: an important candidate regulator for lung diseases. Molecules 28(5):2379PubMedPubMedCentral

Devalaraja S, To TKJ, Folkert IW, Natesan R, Alam MZ, Li M et al (2020) Tumor-derived retinoic acid regulates intratumoral monocyte differentiation to promote immune suppression. Cell 180(6):1098–114.e16PubMedPubMedCentral

Dhawan D, Ramos-Vara JA, Naughton JF, Cheng L, Low PS, Rothenbuhler R et al (2013) Targeting folate receptors to treat invasive urinary bladder cancer. Cancer Res 73(2):875–884PubMed

Doedens AL, Stockmann C, Rubinstein MP, Liao D, Zhang N, DeNardo DG et al (2010) Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 70(19):7465–7475PubMedPubMedCentral

Duan Z, Luo Y (2021) Targeting macrophages in cancer immunotherapy. Signal Transduct Target Ther 6(1):127PubMedPubMedCentral

Fenalti G, Villanueva N, Griffith M, Pagarigan B, Lakkaraju SK, Huang RY et al (2021) Structure of the human marker of self 5-transmembrane receptor CD47. Nat Commun 12(1):5218PubMedPubMedCentral

Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13(5):1472–1479PubMed

Gudgeon J, Marin-Rubio JL, Trost M (2022) The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer. Front Immunol 13:1012002PubMedPubMedCentral

Gurtner A, Manni I, Piaggio G (2017) NF-Y in cancer: impact on cell transformation of a gene essential for proliferation. Biochim Biophys Acta Gene Regul Mech 1860(5):604–616PubMed

Harney AS, Arwert EN, Entenberg D, Wang Y, Guo P, Qian BZ et al (2015) Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discov 5(9):932–943PubMedPubMedCentral

Kalbasi A, Komar C, Tooker GM, Liu M, Lee JW, Gladney WL et al (2017) Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma. Clin Cancer Res 23(1):137–148PubMed

Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A et al (2011) T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 3(95):9573

Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11(5):373–384PubMed

Kelley JL, Ozment TR, Li C, Schweitzer JB, Williams DL (2014) Scavenger receptor-A (CD204): a two-edged sword in health and disease. Crit Rev Immunol 34(3):241–261PubMedPubMedCentral

Koukourakis MI, Kalamida D, Mitrakas AG, Liousia M, Pouliliou S, Sivridis E et al (2017) Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts. Lab Investig J Tech Methods Pathol 97(11):1321–1331

Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T et al (2013) Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat 12(3):259–267PubMed

Li Y, Cao F, Li M, Li P, Yu Y, Xiang L et al (2018) Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages. J Exp Clin Cancer Res 37(1):259PubMedPubMedCentral

Li M, Li M, Yang Y, Liu Y, Xie H, Yu Q et al (2020) Remodeling tumor immune microenvironment via targeted blockade of PI3K-gamma and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy. J Control Release 321:23–35PubMed

Liu J, Xavy S, Mihardja S, Chen S, Sompalli K, Feng D et al (2020) Targeting macrophage checkpoint inhibitor SIRPalpha for anticancer therapy. JCI Insight. https://doi.org/10.1172/jci.insight.134728CrossRefPubMedPubMedCentral

Ma S, Li X, Wang X, Cheng L, Li Z, Zhang C et al (2019) Current progress in CAR-T Cell therapy for solid tumors. Int J Biol Sci 15(12):2548–2560PubMedPubMedCentral

Ma YF, Chen Y, Fang D, Huang Q, Luo Z, Qin Q et al (2021) The immune-related gene CD52 is a favorable biomarker for breast cancer prognosis. Gland Surg 10(2):780–798PubMedPubMedCentral

Mantovani A, Allavena P (2015) The interaction of anticancer therapies with tumor-associated macrophages. J Exp Med 212(4):435–445PubMedPubMedCentral

Nazareth MR, Broderick L, Simpson-Abelson MR, Kelleher RJ Jr, Yokota SJ, Bankert RB (2007) Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol 178(9):5552–5562PubMed

Ngambenjawong C, Gustafson HH, Pun SH (2017) Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 114:206–221PubMedPubMedCentral

Ovais M, Guo M, Chen C (2019) Tailoring nanomaterials for targeting tumor-associated macrophages. Adv Mater 31(19):e1808303PubMed

Ramesh A, Kumar S, Brouillard A, Nandi D, Kulkarni A (2020) A Nitric Oxide (NO) nanoreporter for noninvasive real-time imaging of macrophage immunotherapy. Adv Mater 32(24):e2000648PubMed

Ravi J, Elbaz M, Wani NA, Nasser MW, Ganju RK (2016) Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway. Mol Carcinog 55(12):2063–2076PubMedPubMedCentral

Reyes NJ, O’Koren EG, Saban DR (2017) New insights into mononuclear phagocyte biology from the visual system. Nat Rev Immunol 17(5):322–332PubMedPubMedCentral

Richards DM, Hettinger J, Feuerer M (2013) Monocytes and macrophages in cancer: development and functions. Cancer Microenviron 6(2):179–191PubMed

Rigo A, Gottardi M, Zamo A, Mauri P, Bonifacio M, Krampera M et al (2010) Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. Mol Cancer 9:273PubMedPubMedCentral

Ruffell B, Coussens LM (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27(4):462–472PubMedPubMedCentral

Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA (2008) Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15(4):1069–1074PubMedPubMedCentral

Sanchez-Martin L, Estecha A, Samaniego R, Sanchez-Ramon S, Vega MA, Sanchez-Mateos P (2011) The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 117(1):88–97PubMed

Sarode P, Schaefer MB, Grimminger F, Seeger W, Savai R (2020) Macrophage and tumor cell cross-talk is fundamental for lung tumor progression: we need to talk. Front Oncol 10:324PubMedPubMedCentral

Sawa-Wejksza K, Kandefer-Szerszen M (2018) Tumor-associated macrophages as target for antitumor therapy. Arch Immunol Ther Exp (warsz) 66(2):97–111PubMed

Schultze JL, Schmieder A, Goerdt S (2015) Macrophage activation in human diseases. Semin Immunol 27(4):249–256PubMed

Shi Y, Lammers T (2019) Combining nanomedicine and immunotherapy. Acc Chem Res 52(6):1543–1554PubMedPubMedCentral

Sica A, Allavena P, Mantovani A (2008) Cancer related inflammation: the macrophage connection. Cancer Lett 267(2):204–215PubMed

Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T et al (2010) Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma. N Engl J Med 362(10):875–885PubMedPubMedCentral

Sterner RC, Sterner RM (2021) CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J 11(4):69PubMedPubMedCentral

Stifano G, Christmann RB (2016) Macrophage involvement in systemic sclerosis: do we need more evidence? Curr Rheumatol Rep 18(1):2PubMed

Takahashi R, Ijichi H, Sano M, Miyabayashi K, Mohri D, Kim J et al (2020) Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer. Sci Rep 10(1):21194PubMedPubMedCentral

Timaner M, Bril R, Kaidar-Person O, Rachman-Tzemah C, Alishekevitz D, Kotsofruk R et al (2015) Dequalinium blocks macrophage-induced metastasis following local radiation. Oncotarget 6(29):27537–27554PubMedPubMedCentral

Trauelsen M, Hiron TK, Lin D, Petersen JE, Breton B, Husted AS et al (2021) Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1/GPR91-mediated Gq signaling. Cell Rep 35(11):109246PubMed

Tsai RK, Discher DE (2008) Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol 180(5):989–1003PubMedPubMedCentral

Vernon-Wilson EF, Kee WJ, Willis AC, Barclay AN, Simmons DL, Brown MH (2000) CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1. Eur J Immunol 30(8):2130–2137PubMed

Wang N, Liang H, Zen K (2014) Molecular mechanisms that influence the macrophage m1–m2 polarization balance. Front Immunol 5:614PubMedPubMedCentral

Wang J, Li D, Cang H, Guo B (2019) Crosstalk between cancer and immune cells: role of tumor-associated macrophages in the tumor microenvironment. Cancer Med 8(10):4709–4721PubMedPubMedCentral

Weichand B, Popp R, Dziumbla S, Mora J, Strack E, Elwakeel E et al (2017) S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1beta. J Exp Med 214(9):2695–2713PubMedPubMedCentral

Welsh TJ, Green RH, Richardson D, Waller DA, O’Byrne KJ, Bradding P (2005) Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23(35):8959–8967PubMed

Wu JY, Huang TW, Hsieh YT, Wang YF, Yen CC, Lee GL et al (2020) Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol Cell 77(2):213–27.e5PubMed

Xiao H, Guo Y, Li B, Li X, Wang Y, Han S et al (2020) M2-Like tumor-associated macrophage-targeted codelivery of STAT6 inhibitor and IKKbeta siRNA induces M2-to-M1 repolarization for cancer immunotherapy with low immune side effects. ACS Cent Sci 6(7):1208–1222PubMedPubMedCentral

Xu J, Escamilla J, Mok S, David J, Priceman S, West B et al (2013) CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. Cancer Res 73(9):2782–2794PubMedPubMedCentral

Yang H, Shao R, Huang H, Wang X, Rong Z, Lin Y (2019) Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPa axis. Cancer Med 8(9):4245–4253PubMedPubMedCentral

Zhao H, Song S, Ma J, Yan Z, Xie H, Feng Y et al (2022) CD47 as a promising therapeutic target in oncology. Front Immunol 13:757480PubMedPubMedCentral

Zhou D, Luan J, Huang C, Li J (2021) Tumor-associated macrophages in hepatocellular carcinoma: friend or foe? Gut Liver 15(4):500–516PubMed

Zhu L, Jones C, Zhang G (2018) The role of phospholipase C signaling in macrophage-mediated inflammatory response. J Immunol Res 2018:5201759PubMedPubMedCentral

Zhu Y, Li X, Wang L, Hong X, Yang J (2022) Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment. Front Endocrinol (lausanne) 13:988295PubMedPubMedCentral

Title: Shedding light on macrophage immunotherapy in lung cancer
Authors: Huiyun Ma
Zhouwei Zhang
Qin Hu
Hongyu Chen
Gujie Wu
Youlang Zhou
Qun Xue
Publication date: 13-04-2023
Publisher: Springer Berlin Heidelberg
Keywords: Lung Cancer
Lung Cancer
Lung Cancer
Published in: Journal of Cancer Research and Clinical Oncology / Issue 10/2023
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-023-04740-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2023

Relevance of tumor boards for the inclusion of patients in oncological clinical trials

A clinically applicable prediction model for the risk of in-hospital mortality in solid cancer patients admitted to intensive care units with sepsis

YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma

Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer

Artificial intelligence in oncology: chances and pitfalls

Extracapsular extension of transitional zone prostate cancer miss-detected by multiparametric magnetic resonance imaging

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials